These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18391500)

  • 1. Fibroblast growth factor signaling in cranial suture development and pathogenesis.
    Hajihosseini MK
    Front Oral Biol; 2008; 12():160-177. PubMed ID: 18391500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF signaling in craniofacial biological control and pathological craniofacial development.
    Hatch NE
    Crit Rev Eukaryot Gene Expr; 2010; 20(4):295-311. PubMed ID: 21395503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetics of craniofacial development].
    van Adrichem LN; Hoogeboom AJ; Wolvius EB
    Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):61-8. PubMed ID: 18326400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR-associated craniosynostosis syndromes and gastrointestinal defects.
    Hibberd CE; Bowdin S; Arudchelvan Y; Forrest CR; Brakora KA; Marcucio RS; Gong SG
    Am J Med Genet A; 2016 Dec; 170(12):3215-3221. PubMed ID: 27481450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome.
    Tholpady SS; Abdelaal MM; Dufresne CR; Gampper TJ; Lin KY; Jane JA; Morgan RF; Ogle RC
    J Craniofac Surg; 2004 May; 15(3):431-5; discussion 436-8. PubMed ID: 15111803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
    Ignelzi MA; Wang W; Young AT
    J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the lip and palate: FGF signalling.
    Stanier P; Pauws E
    Front Oral Biol; 2012; 16():71-80. PubMed ID: 22759671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signaling in pathogenesis of craniosynostosis: the role of fibroblast growth factor and transforming growth factor-β.
    Chim H; Manjila S; Cohen AR; Gosain AK
    Neurosurg Focus; 2011 Aug; 31(2):E7. PubMed ID: 21806346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic diversity in patients with craniosynostoses unrelated to Apert syndrome: the role of fibroblast growth factor receptor gene mutations.
    Ito S; Sekido K; Kanno H; Sato H; Tanaka M; Yamaguchi K; Yamamoto I
    J Neurosurg; 2005 Jan; 102(1 Suppl):23-30. PubMed ID: 16206730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular bases of syndromic craniosynostoses.
    Bonaventure J; El Ghouzzi V
    Expert Rev Mol Med; 2003 Jan; 5(4):1-17. PubMed ID: 14987407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cranial suture morphogenesis.
    Ogle RC; Tholpady SS; McGlynn KA; Ogle RA
    Cells Tissues Organs; 2004; 176(1-3):54-66. PubMed ID: 14745235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic FGFR and TWIST mutations are not a common cause of isolated nonsyndromic single suture craniosynostosis.
    Anderson PJ; Cox TC; Roscioli T; Elakis G; Smithers L; David DJ; Powell B
    J Craniofac Surg; 2007 Mar; 18(2):312-4. PubMed ID: 17414280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF signalling in craniofacial development and developmental disorders.
    Nie X; Luukko K; Kettunen P
    Oral Dis; 2006 Mar; 12(2):102-11. PubMed ID: 16476029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
    van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for fibroblast growth factor receptor activation.
    Mohammadi M; Olsen SK; Ibrahimi OA
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis.
    Rice DP; Rice R; Thesleff I
    Eur J Orthod; 2003 Apr; 25(2):139-48. PubMed ID: 12737212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms.
    Agochukwu NB; Solomon BD; Muenke M
    Am J Audiol; 2014 Jun; 23(2):135-41. PubMed ID: 24686979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic effects of fibroblast growth factor receptors in mammalian development.
    McIntosh I; Bellus GA; Jab EW
    Cell Struct Funct; 2000 Apr; 25(2):85-96. PubMed ID: 10885578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.